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Abstract Recently adipose tissue has become a research
topic also for the searching for an alternative stem cells
source to use in cell based therapies such as tissue engineer.
In fact Adipose Stem Cells (ASCs) exhibit an important
differentiation potential for several cell lineages such as
chondrogenic, osteogenic, myogenic, adipogenic and endo-
thelial cells. ASCs populations isolated using standard
methodologies (i.e., based on their adherence ability) are
very heterogeneous but very few studies have analysed this
aspect. Consequently, several questions are still pending, as
for example, on what regard the existence/ or not of distinct
ASCs subpopulations. The present study is originally aimed
at isolating selected ASCs subpopulations, and to analyse
their behaviour towards the heterogeneous population
regarding the expression of stem cell markers and also
regarding their osteogenic and chondrogenic differentiation
potential. Human Adipose derived Stem Cells (hASCs)
subpopulations were isolated using immunomagnetic beads
coated with several different antibodies (CD29, CD44,
CD49d, CD73, CD90, CD 105, Stro-1 and p75) and were
characterized by Real Time RT-PCR in order to assess the
expression of mesenchymal stem cells markers (CD44,
CD73, Stro-1, CD105 and CD90) as well as known
markers of the chondrogenic (Sox 9, Collagen II) and
osteogenic lineage (Osteopontin, Osteocalcin). The
obtained results underline the complexity of the ASCs
population demonstrating that it is composed of several
subpopulations, which express different levels of ASCs
markers and exhibit distinctive differentiation potentials.
Furthermore, the results obtained clearly evidence of the
advantages of using selected populations in cell-based
therapies, such as bone and cartilage regenerative medicine
approaches.
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Introduction
Adipose-derived Stem Cells (ASCs) were firstly identi-
fied in 2001 by Zuk et al. [1] and since then ASCs have
been the focus of many studies envisioning the better
understanding of a number of cellular mechanisms (for
instance involved in adipogenesis) [2, 3] and/or the
application of these cells in a number of cell-based
therapies, including Regenerative Medicine and Tissue
Engineering [4–6]. In fact, the Adipose Tissue, mainly due
to its wide availability and the relative simplicity of the
harvesting procedures, presents a great potential as a
source of adult stem cells for a number of applications as
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compared to other cell sources, such as for instance the
bone marrow [7]. Furthermore, it is critical to develop
therapies that involve a minimal time frame between the
harvesting of the tissue and the application of the cells.
This time consists in the summa of the expansion time to
obtain a clinically relevant number of cells and eventually,
for specific applications, the time needed to differentiate
isolated cells. Obviously this time frame can be shortened
by means of using adequate cell sources and/or specific
harvesting/isolation methods and optimized culturing
conditions. Until now, the most promising strategies in
distinct stem cells therapies are based on the use of
autologous cells and thus it is essential to optimize the
number of cells that can be isolated from relatively small
tissue samples of the patients. From the adipose tissue it is
possible to obtain a high number of stem cells specially
when compared with the bone marrow. In fact, the ratio
between “Colonies-Forming-Unit Fibroblast” (CFU-F)
and “Colonies-Forming-Unit expressing Alkaline Phos-
phatase” (CFU-AP) of the MSCs isolated from bone
marrow is 1 in 100000 and 1 in 100 from ASCs isolated
from an equal amount of Adipose Tissue [7, 8]. Never-
theless, the ASCs have obvious and profound similarities
with the Bone Marrow MSCs (BM-MSCs) as both
represent the stromal cell fraction of adipose tissue and
bone marrow (both derived from the mesenchyme),
respectively, and have similar morphology and surface
proteins [1, 9, 10]. Therefore, most of the research work
that can be found on ASCs is based on previous studies on
BM-MSCs [11]. ASCs have also a great differentiation
potential, demonstrated by a number of studies that have
shown their neurogenic [1, 12, 13], cardiomyocyte and
myocyte [14–17], endothelial cells [1, 15], hepatocytes
[18, 19], adipogenic [1, 20, 21], and of course osteogenic
and chondrogenic differentiation potential [22–26].
Most of the studies on ASCs that can be found in
literature [27–32], describe the isolation of these cells
using a method based on the enzymatic digestion of the
adipose tissue with collagenase, followed by the seeding
of the heterogeneous cell suspension, and subsequent
removal of non-adherent cells. The principle of this
isolation method is the property of the ASCs to adhere
to the surface of the culture flasks/dishes and it obviously
results in the presence of other cell types that may
compromise the proliferation and/or differentiation poten-
tial of ASCs [30, 33–36]. The use of other methods may
allow studying the possible presence of subpopulations,
similarly to what has been found in the bone marrow [37–
40]. In fact several BM-MSC subpopulations have been
studied in order to establish the phenotype, the gene
expression and the proliferation rate as described in a
study by Tormin et al. [39], which identified at least three
different subpopulations; Gronthos et al. [41] were able to
isolate and purify a STRO+/VCAM1+ BM-MSC subpopu-
lation that exhibited high proliferative properties. Studies
on the differentiation potential of the several BM-MSC
subpopulations have also been carried on by Satomura et
al. [42], that showed that not all the stem cells subpopu-
lations that were isolated from the bone marrow were able
to differentiate into osteoblasts. Other studies suggested
the presence of specific subpopulations in the bone
marrow that have higher ability for the differentiation into
the lipogenic lineage while other subpopulations present a
superior ability for the osteogenic differentiation [37–39,
43–46]. These studies clearly demonstrate the presence of
subpopulations in the BM-MSC and highlight the impor-
tance of developing isolation methods that allow obtaining
selected cells populations and studing the characteristics
that differ among them. However, a very limited number
of such studies on ASCs is reported in the literature [47,
48]. Miranville et al [49] and Sengenes et al [48], with the
objective of studying the neovascularisation and the
angiogenesis in the adipose tissue, used a method that
consisted in the selection of the ASCs using immunomag-
netic beads coated with CD34 antibody followed by FACS
analysis. This research group published several further
studies [47, 48] where ASCs CD34+/CD31+ were isolated
with the aim to study the vascularisation in the adipose
tissue and the potential of these stem cells to differentiate
into the endothelial lineage and they have demonstrated
that at least one subpopulation of ASCs has this
differentiation potential.
In this work, we hypothesised that there are of several
subpopulations whitin the vascular fraction of the
adipose tissue and consequently ASCs, obtained after
enzymatic digestion, were selected using immunomag-
netic beads coated with a range of antibodies, namely,
CD29 ab, CD44 ab, CD49d ab, CD73 ab, CD90 ab,
CD105 ab, p75 ab and STRO-1 ab. The selection of the
majority of these antibodies was based on the ASCs gene
expression profile, as it is know that ASCs express
CD29, CD44, CD49d, CD90, CD73, and CD105 among
others, such as CD49e and CD166 [7–9, 24, 34, 35].
STRO-1 was chosen because it has been used in previous
studies to select subpopulation of BM-MSCs [40, 41, 50,
51] and p75 was selected because it was the first marker to
be commercialized for the isolation of BM-MSCs. The
“stemness” [52] of the subpopulations was characterized
through the analysis of the expression of MSC markers, as
described by the Mesenchymal and Stem Cells Committee
of the International Society for Cellular Therapy. The
differentiation potential of the several subpopulations
cultured using either osteogenic and chondrogenic induc-
ing medium was also characterized through Real-Time
RT-PCR and specific histological staining for osteogenic
and chondrogenic differentiation, respectively.
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Materials and Methods
Harvesting and Isolation of Adipose Derived Stem
Cells (ASCs)
Human subcutaneous adipose tissue samples were obtained
from lipoaspiration procedures performed on women with
ages between 35 and 45 years, under a protocol previously
established with the Department of Plastic Surgery of
Hospital da Prelada, in Porto, Portugal.
All the samples were processed within 24 h after the
lipoaspiration; 300×g circa of each sample were retrieved
and processed for the isolation of hASCs. The lipoaspirate
samples were firstly washed with a solution of PBS (Sigma
Aldrich, Germany), 5 mg/500 mL Ciprobay 200 (Bayer,
Germany) and 10% Antibiotic-Antimycotic (Gibco, UK),
and then digested with 0.2% collagenase type I A (Sigma
Aldrich, Germany) in PBS for 60 min at 37°C under gentle
stirring. The digested tissue was filtered using a 100 μm
filter mesh (Sigma Aldrich, Germany) and centrifugated at
800×g for 7 min at 20°C and the supernatant removed. The
obtained cells were resuspended in culture medium (basal
medium) composed by D-MEM-LG (Sigma Aldrich,
Germany), 10% FBS (Gibco, UK) and 1% Antibiotic-
Antimycotic (Gibco, UK) and seeded in 75 cm2 culture flasks
and incubated at 37°C with 5% CO2 (cells corresponding to
the Vascular Fraction, VF) or submitted to a method for
selection of subpopulations as described bellow.
Isolation of ASCs Using Immunomagnetic Beads
To isolate subpopulations within the heterogeneous popu-
lation of cells obtained after the enzymatic digestion as
described above, it was optimized a method based on the
use of immunomagnetic beads previously coated with
different antibodies. The VF of each patient was divided
in different fractions and for each fraction was performed a
separation process with one of the antibodies selected. For
this procedure it was selected the Dynal M-450 Epoxy
beads (Dynabeads, Dynal Biotech, USA), which were
prepared according to the instructions, provided by the
manufacture (Dynal Biotech, USA). Briefly, the beads were
coated, through 24 h incubation under gentle stirring in
sodium phosphate buffer at room temperature, respectively
with the anti human CD29 (Integrin, beta 1; Enzifarma,
Portugal), CD44 (CD44 molecule (Indian blood group);
Enzifarma, Portugal), CD49d (Integrin alpha 4; Serotec,
USA), CD73 (5′ nucleotidase, ecto; Enzifarma, Portugal),
CD90 (Thy-1 cell surface antigen; eBioscience, USA),
CD105 (Endoglin; eBioscience, USA), p75 (Nerve Growth
Factor Receptor; ABCam, USA) or STRO-1 (Stromal
Derived Factor 1; Santa Cruz Biotechnology, Inc., USA)
antibody, using a concentration of 4 μg of antibody for 1×107
Dynabeads. The cell pellet obtained upon the enzymatic
digestion of the lipoaspirate samples was resuspended in a
0.1% BSA solution (Sigma Aldrich, Germany) in PBS
(Sigma Aldrich, Germany) and then mixed with the Ab-
coated Dynabeads and incubated for 30 min at 4°C, under
gentle stirring, to promote the bonding between cells and the
beads. Subsequently, the cells suspension and beads mixture
was washed with PBS and 0.1% BSA and the cells bonded
to the Ab-coated Dynabeads were separated from the
remaining of the cell suspension using the Dynal MPC
magnet (Dynal Biotech, USA). Finally, the cells bonded to
the Ab-coated Dynabeads were seeded in 75 cm2 cell culture
flasks and incubated at 37°C with 5% CO2.
Characterization of the Cells Isolated Using
the Immunomagnetic Beads Coated
with Different Antibodies
All the cell populations isolated using the immunomagnetic
beads coated with the different antibodies were cultured in
75 cm2 flask with basal medium, until confluence.
For evaluation of the expression of mesenchymal stem
cells markers by the isolated subpopulations, as compared to
the whole population obtained by the enzymatic procedure,
Real-Time RT-PCR analysis was used to assess the expression
of several markers known to be expressed by stem cells, such
as CD44; CD73; STRO-1; CD105 and CD90. Furthermore,
the isolated subpopulations were also cultured with specific
chondrogenic and osteogenic medium in order to assess their
differentiation potential into these lineages. Histological
stainings and Real Time RT-PCR analysis were used to
evaluate the ostogenic and chondrogenic differentiation
potential, as it will be described in further sections.
Expression of Mesenchymal Stem Cells Markers
After reaching confluence (80% of total flask surface), all
subpopulations were trypsinized and sub-cultured into
25 cm2 flasks for 10 days, using basal medium. The total
RNA was extracted with TriZol Reagent (Invitrogen, USA)
following the procedure provided by the supplier: briefly,
800 μl of TriZol were added for each sample containing
1×106 cells. After an incubation of 5 min, additional 160 μl
of chloroform (Sigma Aldrich, Germany) were added; the
samples were then incubated for 15 min at 4°C and
centrifuged at the same temperature and 13000×g for
15 min. After the centrifugation, the aqueous part was
collected and an equal part of isopropanol (Sigma Aldrich,
Germany) was added. After an incubation of 2 h at −20°C
the samples were washed in ethanol, centrifuged at 4°C and
9000×g for 5 min and resuspended in 12 μl of water
RNase/DNase free (Gibco, UK). The samples were quan-
tified using the NanoDrop ND-1000 Spectrophotometer
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(NanoDrop Technologies, USA). For the cDNA synthesis
the samples with a 260/280 ratio between 1.7 and 2.0 were
used. The cDNA synthesis was performed using the iScript
cDNA synthesis Kit (BioRad, USA), and the MiniOpticom
Real-Time PCR Detection System (BioRad, USA), using an
initial amount of total RNA of 2 μg and a total volume of
20 μl. RNAse free water (Gibco, UK) was used as a
negative control.
After the synthesis of the cDNA, the cells cultured with
D-MEM were investigated regarding the expression of the
genes CD73, STRO-1, CD105, CD90, and CD44. For each
sample, GAPDH was used as housekeeping gene. The
primers have been designed using the Primer 3 online
software (v 0.4.0) and synthesized by MWG Biotech
Germany (Table 1).
The Real Time PCR was carried out using iQ Syber
Green SuperMix equipment (BioRad, USA); reactions were
performed following the procedure suggested by the
manufacturer. To analyze the obtained data it was used
the Delta Delta Ct method. The Delta Delta Ct was
calculated using as reference sample the results obtained
from the stromal vascular fraction. The results calculated as
2 -ΔΔCt and were elaborated using the Origin Pro 7.0
(OriginLab Corporation, USA) and the correlation between
the dataset from the same gene analyzed was investigated
with the ANOVA single factor method.
Assessment of the Osteoblastic Differentiation
For assessment of the osteoblastic differentiation potential of
the cells isolated using the different procedures described, the
cells were seeded in 25 cm2 flasks and cultured using basal
medium (as control), and osteogenic medium composed of
alpha modified eagle medium (α-MEM, Sigma Aldrich,
Germany), supplemented with 50 μg/ml ascorbic acid
(Sigma Aldrich, Germany), 10−8 M dexamethasone (Sigma
Aldrich, Germany), 10 mM β-glycerol phosphate (Sigma
Aldrich, Germany), 10% FBS (Gibco, UK) and 1%
antibiotic/antimycotic (Gibco, UK).
After 3 weeks of culture with osteogenic medium,
samples were retrieved for alizarin red-S staining and Real
Time RT-PCR analysis for osteopontin and osteocalcin.
Alizarin Red Staining
The cells were fixed with formalin (Sigma Aldrich,
Germany) and washed first with PBS and then with
distilled water. Then the cells were stained with a 2%
Alizarin Red solution (Merck, Germany) in distilled water
for 5 min, and finally washed with distilled water. Cultures
were observed under an inverted microscope (Axivert 40
CFL, Zeiss, Germany).
Osteopontin and Osteocalcin Expression
Osteopontin and osteocalcin expression was assessed
through Real Time RT-PCR analysis, which was performed
as described for the analyses of mesenchymal stem cell
markers expression. In this case the Delta Delta Ct was
calculated using the osteopontin and osteocalcin expression
of the cells cultured with basal medium as control. The
primers used were reported in Table 1.
Assessment of the Chondrogenic Differentiation Potential
For the assessment of the chondrogenic differentiation
potential, the cells were cultured in the form of pellets
(obtained by centrifugation at 800 g of 5×106 cells). For
each subpopulation, 6 pellets have been cultured with
chondrogenic medium composed of D-MEM (Sigma
Aldrich, Germany) supplemented with 1 mM dexametha-
sone (Sigma Aldrich, Germany), 0.1 M sodium pyruvate
(Sigma Aldrich, Germany), 17 mM ascorbic acid (Sigma
Aldrich, Germany), 35 mM proline (Fluka, Germany), ITS
(Sigma Aldrich, Germany), 1% antibiotic/antimycotic
(Gibco, UK), 10 ng/ml TGF-β1 (Pepro-Tech, USA) and
10% FBS (Gibco, UK) for 3 weeks in 15 ml Falcons tube.
At the end of the third week of culture, the pellets were
Table 1 Summary of the primers used in this study to perform RT Real Time PCR
Primer name Sequence FW Sequence RW NCBI Reference sequence
GAPDH GCGACGGCTATGATTACGAT ACTTGGAGGCAGTCCAGAGA NM_002046.3
CD105 TCCTCCCAAGGACACTTGTA CGCCTCATTGCTGATCATAC NM_001114753
CD44 GTTGCCAAACCACTGTTCCT CATTCAAATCCGGAATGCT NM_000610
STRO-1 GAAGCTAAAGTGGATTCAGGAGTA TAAGCAGGGGACCATTACA DQ345517
CD73 CGCAACAATGGCACAATTAC CTCGACACTTGGTGCAAGA NM_002526
Osteocalcin GGCAGCGAGGTAGTGAAGAG CTGGAGAGGAGCAGAACTGG NM_099173
Osteopontin CCCACAGACCCTTCCAAGTA GGGGACAACTGGAGTGAAAA NM_001040058
Collagen II GACAATCTGGCTCCCAAC ACAGTCTTGCCCCACTTAC NM_001844
Sox 9 TACGACTACACCGACCACCA TTAGGATCATCTCGGCCATC NM_000346
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collected and were used for histological analysis (toluidine-
blue and safranin-O staining) and for Real Time RT-PCR
for Collagen II and SOX 9.
Toluidine-Blue and Safranin-O Staining
The pellets were fixed in formalin and embedded in
paraffin. The pellets were cut into sections of 8 μm, fixed
on a slide and deparaffinated. Sections were stained by
adding one drop of 1% toluidine blue onto each section for
2–3 s; and then safranin-O staining was also performed
adding one drop of 0.1% safranin-O solution onto each
section for 5 min. In both cases, the stained sections were
subsequently rinsed with distilled water and dehydrated
using 100% ethylene alcohol and allowed to dry overnight.
The stained samples were analysed under a optical Imager.
Z1 fluorescence microscope (Axivert 40 CFL; Zeiss,
Germany) and photographed using an Axio Cam MRm
camera (Zeiss, Germany).
Collagen II and Sox 9 Expression
Collagen II, Sox 9 and Aggrecan expression was assessed
on cell pellets cultured for 3 weeks in chondrogenic
medium, performing the Real Time RT-PCR as described
in “Expression of Mesenchymal Stem Cells Markers”
section. The primers used were reported in Table 1.
The Delta Delta Ct was calculated using the collagen II,
sox 9 and aggrecan expression of the cells cultured with
Basal Medium as control.
Statistical Analysis
Data are presented as arithmetic mean±SD. An ANOVA
Single Factor Test was used to compare the mean values of
the results obtained from Real-Time RT-PCR analysis. The
reference sample considered was the Vascular Fraction
(VF). Differences were considered to be significant for p<
0.05. All statistical tests were performed using Origin Pro
7.0 (OriginLab Corporation, USA).
Results
Stem Cells Characterization: Real Time RT-PCR
The results obtained from the Real Time RT-PCR analysis
regarding the expression of STRO-1, CD44, CD73, CD90
and CD105 in each of the isolated subpopulations are
summarized in Table 2. The results showed in the Fig. 1
depict a complex scenario where not all the isolated
subpopulations express the same gene profile and/or where
not all the gene expression levels are higher than the T
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vascular fraction (VF) represented by the baseline. Never-
theless all the subpopulations isolated showed clearly a
lower expression of STRO-1, CD105 and CD44 compared
with the VF, while in what concerns to the gene CD73 only
the subpopulation isolated with the immunomagnetic beads
coated with p75 and STRO-1 ab, presented a lower
expression than that registered for the VF.
Osteogenic Differentiation Potential
Alizarin Red Staining
After 3 weeks of culture with osteogenic medium, all the
cells subpopulations isolated with the different antibodies
were positively stained for Alizarin Red, as it showed in
Fig. 2, demonstrating the occurrence of the mineralization
process. However, cell populations obtained from the
enzymatic digestion (VF) (data not shown) and the
subpopulation isolated with the immunomagnetic beads
coated with anti STRO-1 Ab showed a more intensive
staining, indicating the accuracy of a more widespread
mineralization process.
Real Time RT-PCR for Osteocalcin and Osteopontin
After the osteogenic differentiation, Real Time RT-PCR
analysis was performed in order to study the expression
of osteopontin and osteocalcin, an early and a late
marker of the osteogenic differentiation, respectively
Fig. 1 Graphical representation of the Real Time RT-PCR analysis
results of the various genes analysed by the ASCs isolated with the
enzymatic digestion only (a) and by the subpopulations isolated using
the immunomagnetic beads coated with the different antibodies,
namely: b ASCs isolated with anti CD29 antibody; c ASCs isolated
with anti CD44 antibody; d ASCs isolated with anti CD73 antibody; e
ASCs isolated with anti CD105 antibody; f ASCs isolated with anti
CD49d antibody; g ASCs isolated with anti p75 antibody; h ASCs
isolated with anti STRO-1 antibody; i ASCs isolated with anti CD90
antibody; (ANOVA single factor; p<0.05)
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[53, 54]. The results obtained are reported in Fig. 3
while the statistical analysis are reported in Table 3 and,
in general, show a down regulation of osteopontin
contrasted by an up regulation of osteocalcin. These
results are in agreement with the images obtained from
the Alizarin red stained sections, and confirm the
occurrence of the osteogenic differentiation process and
subsequent mineralization.
However only few of these isolated subpopulations have
an higher expression rate of osteopontin in respect to the
Vascular Fraction; namely the ASCs subpopulation isolated
with anti CD49d ab; with anti CD90 antibody and with anti
p75 antibody.
Regarding the expression of osteocalcin, all the
subpopulation isolated expressed this gene. Furthermore
in all the cases the expression of osteocalcin is at least
ten times higher than osteopontin, demonstrating that the
differentiation process has already reached an advanced
stage. This is particularly evident in the cells isolated
with the antibody anti STRO-1 coated beads, that
showed an intensive staining in the alizarin red assay
and simultaneously a quite low expression of osteocalcin,
suggesting that the differentiation process of this cells
subpopulation is so advanced that the expression of this
gene started to drop down.
Chondrogenic Differentiation Potential
Toluidin Blue and Safranin-O Staining Assay
After 3 weeks of pellet culture with chondrogenic medium
all the isolated subpopulations were positively stained with
toluidin blue and safranin-O showing the production of
extracellular matrix (see Fig. 4).
Fig. 2 Optical microscope pictures showing the cells obtained using the
different isolation procedure stained, cultured with osteogenic medium
and stained for alizarin red: a human ASCs isolated with immunomag-
netic beads coated with anti CD29 ab (100×); b human ASCs isolated
with immunomagnetic beads coated with anti CD44 ab (100×); c human
ASCs isolated with immunomagnetic beads coated with anti CD49d ab
(100×); d human ASCs isolated with anti p75 ab (100×); e human
ASCs isolated with anti CD105 ab (100×); f human ASCs isolated with
anti CD73 ab (100×); g human ASCs isolated with anti CD90 ab
(100×); h human ASCs isolated with anti STRO-1 ab (100×)
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Real Time RT-PCR for Collagen II and Sox 9
After 3 weeks of culture with chondrogenic medium, Real
Time RT-PCR was performed in order to evaluate the
expression of Sox 9 and collagen II, in each one of the
isolated subpopulations. Sox 9 is a regulatory early marker
of the chondrogenic differentiation process and collagen II
is a well known marker of the extracellular matrix and
therefore usually expressed at the end of the chondrogenic
process [55, 56]. The results are reported in the Fig. 3 while
the statistical analysis are reported in Table 3. All the cells
isolated with the immunomagnetic beads coated with the
antibodies used, except the cells CD49d+, express Collagen
II. Sox 9 was also found to be expressed by all the
subpopulations isolated.
Nevertheless, the cell subpopulations studied showed
different expression levels of the chondrogenic genes
considered. In fact, the cell subpopulations that showed
the highest expression of the Sox 9 gene, were those
isolated with the immunomagnetic beads coated with anti
CD44 Ab, p75 Ab and CD105 Ab, while regarding the
expression of collagen II, the highest levels of expression
were detected in the cell subpopulations isolated with anti
CD29 Ab, CD73 Ab and CD105 Ab.
Discussion
To our best knowledge the present study reports, for the
first time, the identification of a number of subpopula-
Fig. 3 Graphical representation of the results obtained from Real
Time RT-PCR analysis regarding the expression of different chondro-
genic and osteogenic marker genes according to the ASCs isolation
procedure used, namely a ASCs isolated with immunomagnetic beads
coated with anti CD105 antibody; b ASCs isolated with immuno-
magnetic beads coated with anti CD29 antibody; c ASCs isolated with
immunomagnetic beads coated with anti CD44 antibody; d ASCs
isolated with immunomagnetic beads coated with anti CD49d
antibody; e ASCs isolated with immunomagnetic beads coated with
anti CD73 antibody; f ASCs isolated with immunomagnetic beads
coated with anti CD90 antibody; g ASCs isolated with immunomag-
netic beads coated with anti p75 antibody; h ASCs isolated with
immunomagnetic beads coated with anti STRO-1 antibody. Results
analysed using ANOVA single factor; p<0.05
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Table 3 Summary table of the results obtained from the statistical
analysis of Real Time RT-PCR data regarding the expression of the
differentiation marker considered by all the ASCs subpopulations
isolated, showing the all statistical significant different (p<0.05) levels
of expression found. On the upper row and left column in bold are
reported the subpopulations isolated with the different antibodies. In the
intersection of each column/row are identified the markers that showed
significant different expression levels for that two subpopulations
ASCs isolated with immunomagnetic beads coated with Ab
ASCs isolated with
immunomagnetic beads
coated with Ab
CD105 CD29 CD44 CD49d CD73 CD90 P75 Stro-1
CD105 Col II Sox 9 OP OP Sox 9 OP Col II
CD29 Col II OP OC
CD44 Col II Sox 9 Col II Col II Sox 9 OP Col II Sox 9 OP OC Col II OP OC
CD49d Col II Sox 9 Col II Sox 9 Sox 9
CD73 OP OP OP OC
CD90 Col II Sox 9 Col II Sox 9 Col II
p75 OP Sox 9 OP OP OC Sox 9 OP OC Col II OP
Stro-1 OP Col II OC Col II op OC OP
Fig. 4 Optical microscope pictures showing the cells obtained using
the different isolation procedure, cultured in chondrogenic medium
and stained for Safranin-O and Toluidin Blue a hASCs isolated with
immunomagnetic beads coated with anti CD29 ab (100×); b hASCs
isolated with immunomagnetic beads coated with anti CD44 ab
(100×); c hASCs isolated with immunomagnetic beads coated with
anti CD49d ab (100×); d hASCs isolated with anti CD73 ab (100×); e
hASCs isolated with anti CD90 ab (100×); f hASCs isolated with anti
CD105 ab (100×); g hASCs isolated with anti STRO-1 ab (100×);
h hASCs isolated with anti p75 ab (100×)
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tions of adult adipose tissue derived stem cells. ASCs
subpopulations were isolated using immunomagnetic
beads coated with different antibodies and then it was
determined the expression level of genes that have been
considered in many studies as markers for the adipose
tissue-derived stem cells. Moreover the ASCs isolated
subpopulations were tested regarding their osteogenic
and chondrogenic differentiation potential, envisioning
their target application in osteo/cartilage tissue engineer-
ing applications.
For a more comprehensive discussion of the results
obtained, it is necessary to analyse separately the
expression of the stem cell markers genes and the data
obtained from the differentiation potential experiments.
The expression of the considered typical markers of
ASCs shows that in the ASCs population (resulting from
the enzymatic digestion only) co-exist several subpopu-
lations that present some common markers expression,
such as in the case of the cells isolated with immuno-
magnetic beads coated with anti CD29 and CD73
antibodies, that are not statistically significant different
in the expression of CD105 and CD44 markers but show
statistically different expression level of the CD73 and
CD90 markers, for example.
The example described above can be applied to all the
cell subpopulations isolated and the differences/analogies
between the several cell subpopulations are summarized in
the Table 2, where all the statistically differences found
between the distinct subpopulations are summarized.
Nevertheless, in all the ASCs subpopulations, except the
one isolated with the immunomagnetic beads coated with
anti STRO-1 ab and anti p75 ab, it is possible to observe a
common signature, where even if the level of expression
differs, the ratio between the analyzed markers is con-
served. In fact, the CD73 is the highest marker to be
expressed followed by CD105; CD90; CD44 and STRO-1.
As mentioned, the subpopulations isolated with anti
STRO-1 ab and p75 ab differs from all the other
showing the highest expression with CD90 followed by
CD105; CD44; CD73 and STRO-1.
Fig. 5 Graphical representation of the results obtained from Real
Time RT-PCR analysis regarding the expression of different chondro-
genic and osteogenic marker genes of the different hASCs subpopu-
lations isolated a Osteopontin gene expression; b Osteocalcin Gene
Expression; c Collagen II Gene Expression; d Sox 9 Gene Expression.
Results analysed using ANOVA single factor; p<0.05
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The assays performed to assess the chondrogenic and
osteogenic differentiation potential show that all the
subpopulations isolated can differentiate into these two
lineages but the subpopulations have different differentia-
tion potential (Fig. 5).
In fact, even if the alizarin red staining is positive for
all the subpopulations isolated, as well as the expression
of osteopontin and osteocalcin, the subpopulation found
more suitable for the osteogenic differentiation is the one
isolated with the immunomagnetic beads coated with anti
STRO-1 antibody. The alizarin red staining of the cells
isolated with anti STRO-1 ab showed an intense
mineralization. In fact, considering the gene expression
it is possible to appreciate correspondent low levels of
osteopontin and five times higher levels of osteocalcin
expression, demonstrating that these cells are in an
advanced stage of the osteogenic differentiation [53, 54,
57]. Additionally, the levels of osteocalcin expression of
the cells isolated with STRO-1 are lower when compared
with the cells isolated with the other antibodies because
the differentiation process of the STRO-1+ population
have already reached the stage where the extracellular
matrix is over produced and the down-regulation of
osteocalcin is just beginning [57] (Figs. 3 and 5).
Regarding the chondrogenic differentiation, all the
subpopulation isolated showed a chondrogenic potential,
as all were found to be positively stained for safranin-O
and toluidin and/or expressed sox-9 and collagen II.
Similarly to previous statements on the osteogenic
differentiation, the results obtained allowed to conclude
that not all the cell subpopulations are in the same stage
of the chondrogenic differentiation process after 3 weeks
of culture. In fact, while all the cells isolated express
sox-9, indicating that they are between the stages of
prechondrocyte and columnar chondrocyte [56], the ASCs
isolated with the immunomagnetic beads coated with anti
CD44 and anti STRO-1 antibodies, do not express collagen II
showing that these subpopulations are still in an early
chondrogenic stage. The ASCs subpopulations that show the
highest chondrogenic differentiation potential are those ones
isolated with the immunomagnetic beads coated with anti
CD105 and the anti CD29 antibody. These subpopulations
exhibit a lower expression of the sox-9 gene and higher
expression of collagen II, indicating that sox-9 has been
down regulated while collagen II is being up-regulated
suggesting that, the cells are reaching the stage of
prehypertrophic chondrocytes, that is a late chondrogenic
differentiation status [55, 56] (Figs. 3 and 5).
The results obtained from this study allow for the
conclusion that among all the ASCs subpopulations
isolated, the cells isolated with immunomagnetic beads
coated with anti STRO-1 ab show the highest osteogenic
potential while the ones isolated using immunomagnetic
beads coated with anti CD29 ab and anti CD105 ab have
the highest chondrogenic differentiation potential.
Furthermore, the results obtained from the induction of
the osteogenic and chondrogenic differentiation underline
that not all the subpopulations are suitable for both
differentiation lineages considered. For example, the cells
isolated with anti CD90 ab, anti CD49d ab and anti p75 ab
exhibited a high osteogenic differentiation potential, but
demonstrated the lowest chondrogenic differentiation po-
tential. On the other hand, the cells isolated with anti CD73
ab exhibited a high chondrogenic differentiation potential
and simultaneously the lowest osteogenic potential.
The results obtained in the present study clearly
demonstrate that the vascular fraction of the adipose tissue
is composed by several stem cell subpopulations that
exhibit a common expression profile for some markers,
but show clear differences when other markers are
considered. Moreover, the data described demonstrated that
the cells subpopulations have different in vitro chondro-
genic or osteogenic differentiation profiles. In fact, the
combination of the results analysed allowed us to select the
subpopulation that can have higher potential application in
bone and/or cartilage regenerative medicine approaches. In
summary and most importantly, this study highlights the
importance of studying ASCs subpopulations and opens the
way to other research studies that can provide significative
further knowledge on ASCs.
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